MSA 174.02 ▲ 0.22% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MSA Safety

    NYSE: MSA · Real-Time Price · USD
    174.02
    0.39 (0.22%)
    At close: Oct 03, 2025, 3:59 PM
    174.00
    -0.01%
    After-hours: Oct 03, 2025, 06:28 PM EDT
    0.22%
    Bid 173.9
    Market Cap 6.81B
    Revenue (ttm) 1.83B
    Net Income (ttm) 276.97M
    EPS (ttm) 7.01
    PE Ratio (ttm) 24.82
    Forward PE 19.82
    Analyst Hold
    Dividends $2.59
    Ask 174.21
    Volume 108,741
    Avg. Volume (20D) 224,176
    Open 174.34
    Previous Close 173.63
    Day's Range 173.19 - 175.24
    52-Week Range 127.86 - 182.86
    Beta 0.99
    Ex-Dividend Date Aug 15, 2025

    About MSA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol MSA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for MSA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    MSA Safety is scheduled to release its earnings on Oct 22, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    news image

    1 week ago · businesswire.com

    Pinnacle Is the No. 1 Bank in the Nashville MSA by Deposits for the Eighth Consecutive Year, Holds No.

    NASHVILLE, Tenn.--(BUSINESS WIRE)--Pinnacle Financial Partners (Nasdaq/NGS: PNFP) remains the largest bank in the Nashville MSA by deposits, marking eight consecutive years at No. 1. According to FDIC...

    news image

    1 month ago · proactiveinvestors.com

    Tiziana Life Sciences doses first MSA patient in new trial – ICYMI

    Tiziana Life Sciences Ltd (NASDAQ:TLSA) CEO Ivor Elrifi talked with Proactive about the company's latest milestone: dosing the first patient in its Phase 2a clinical trial targeting multiple system at...

    news image

    1 month ago · proactiveinvestors.com

    Tiziana Life Sciences doses first patient in Phase 2a MSA trial

    Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has enrolled and dosed the first participant in its Phase 2a clinical trial evaluating intranasal foralumab in patients with Multiple System A...

    news image

    2 months ago · seekingalpha.com

    MSA Safety Incorporated (MSA) Q2 2025 Earnings Conference Call Transcript

    MSA Safety Incorporated (NYSE:MSA ) Q2 2025 Earnings Call August 5, 2025 10:00 AM ET Company Participants Elyse L. Brody - Interim Chief Financial Officer Lawrence Tighe De Maria - Executive Director ...

    news image

    2 months ago · fool.com

    MSA (MSA) Earnings Beat Estimates

    MSA (MSA) Earnings Beat Estimates

    news image

    2 months ago · zacks.com

    MSA Safety (MSA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

    Although the revenue and EPS for MSA Safety (MSA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street...

    news image

    2 months ago · zacks.com

    MSA Safety (MSA) Q2 Earnings and Revenues Top Estimates

    MSA Safety (MSA) came out with quarterly earnings of $1.93 per share, beating the Zacks Consensus Estimate of $1.76 per share. This compares to earnings of $2.01 per share a year ago.

    news image

    2 months ago · zacks.com

    Analysts Estimate MSA Safety (MSA) to Report a Decline in Earnings: What to Look Out for

    MSA Safety (MSA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Add to Watchlist